Sai K, Saito Y, Tatewaki N, Hosokawa M, Kaniwa N, Nishimaki-Mogami T, Naito M, Sawada J, Shirao K, Hamaguchi T, Yamamoto N, Kunitoh H, Tamura T, Yamada Y, Ohe Y, Yoshida T, Minami H, Ohtsu A, Matsumura Y, Saijo N, Okuda H (2010) <br />Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients<br /><i>British Journal of Clinical Pharmacology</i> <b>70</b>: 222<br /><br />Kim SR, Sai K, Tanaka-Kagawa T, Jinno H, Ozawa S, Kaniwa N, Saito Y, Akasawa A, Matsumoto K, Saito H, Kamatani N, Shirao K, Yamamoto N, Yoshida T, Minami H, Ohtsu A, Saijo N, Sawada J (2007) <br />Haplotypes and a novel defective allele of CES2 found in a Japanese population<br /><i>Drug Metabolism & Disposition: The Biological Fate of Chemicals</i> <b>35</b>: 1865<br /><br />Nakajima Y, Saito Y, Shiseki K, Fukushima-Uesaka H, Hasegawa R, Ozawa S, Sugai K, Katoh M, Saitoh O, Ohnuma T, Kawai M, Ohtsuki T, Suzuki C, Minami N, Kimura H, Goto Y, Kamatani N, Kaniwa N, Sawada J (2005) <br />Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients<br /><i>European Journal of Clinical Pharmacology</i> <b>61</b>: 25<br /><br />Sai K, Kaniwa N, Ozawa S, Sawada JI (2001) <br />A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4<br /><i>Drug Metabolism & Disposition: The Biological Fate of Chemicals</i> <b>29</b>: 1505<br /><br />